We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
QCMC
1351
Quantum Capital Management (California)
California
$1.08M -$90.8K -2,887 -8%
MWP
1352
MYCIO Wealth Partners
Pennsylvania
$1.08M +$60.5K +1,924 +6%
DDC
1353
DF Dent & Co
Maryland
$1.08M +$19.2K +609 +2%
LWAC
1354
Laurel Wealth Advisors (California)
California
$1.08M +$1.11M +35,172 New
AWM
1355
Avior Wealth Management
Nebraska
$1.07M +$50.5K +1,606 +5%
VCM
1356
Violich Capital Management
California
$1.07M -$3.08K -98 -0.3%
TAM
1357
Troy Asset Management
United Kingdom
$1.06M
SSWM
1358
Sheets Smith Wealth Management
North Carolina
$1.06M +$14.4K +459 +1%
SFSIG
1359
San Francisco Sentry Investment Group
California
$1.06M +$4.12K +131 +0.4%
SSG
1360
Summit Securities Group
New York
$1.06M +$149K +4,743 +16%
EWA
1361
Exencial Wealth Advisors
Oklahoma
$1.05M +$63.2K +2,010 +6%
FSA
1362
Franklin Street Advisors
North Carolina
$1.05M -$20.2K -643 -2%
SC
1363
Sculptor Capital
New York
$1.04M +$1.07M +34,135 New
ITIM
1364
Indiana Trust & Investment Management
Indiana
$1.04M +$237K +7,530 +27%
OP
1365
Oldfield Partners
United Kingdom
$1.04M
SC
1366
Searle & Co
Connecticut
$1.04M -$1.08M -34,432 -50%
RIA
1367
Regal Investment Advisors
Michigan
$1.04M +$341K +10,852 +47%
DWM
1368
Destination Wealth Management
California
$1.04M +$16K +510 +2%
REMPR
1369
Roof Eidam Maycock Peralta (REMP)
California
$1.03M -$6.64K -211 -0.6%
GIM
1370
Greylin Investment Management
Virginia
$1.02M -$41.4K -1,317 -4%
TCM
1371
Tradition Capital Management
New Jersey
$1.02M
FIM
1372
Freedom Investment Management
Connecticut
$1.02M +$815K +25,896 +351%
BCP
1373
Berkeley Capital Partners
Georgia
$1.01M +$1.04M +32,933 New
PFBT
1374
Parkside Financial Bank & Trust
Missouri
$1M -$22.8K -724 -2%
ARMC
1375
American Research & Management Company
Massachusetts
$1M -$61.6K -1,958 -6%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.